Literature DB >> 14717264

Acetaminophen overuse in the Ohio Medicaid population.

Pamela C Heaton1, Robert J Cluxton, Charles J Moomaw.   

Abstract

OBJECTIVE: To examine patterns of use of acetaminophen in patients with and without risk factors for hepatotoxicity in the Ohio Medicaid population.
DESIGN: Retrospective, cross-sectional analysis of claims data.
SETTING: Ohio. PATIENTS: Ohio Medicaid patients (n = 22,496) who received at least 6 prescriptions for acetaminophen from November 1998 through April 1999. MAIN OUTCOME MEASURE: Overuse of acetaminophen, defined as an average daily dose (ADD) greater than or equal to 4 grams/day or an ADD of greater than or equal to 3 grams/day along with diagnosis codes suggesting underlying liver dysfunction.
RESULTS: We identified 687 patients (3.05%) who received either greater than or equal to 4 grams/day or greater than or equal to 3 grams/day and had diagnosis codes suggesting underlying liver dysfunction (n = 128).
CONCLUSION: Although the number is relatively small, some Ohio Medicaid patients are receiving acetaminophen doses that exceed safety recommendations. Because acetaminophen overuse is the leading cause of liver failure, health care professionals should be alert to the possibility of acetaminophen overuse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14717264     DOI: 10.1331/154434503322642606

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  5 in total

1.  Prescription-acquired acetaminophen use and potential overuse patterns: 2001-2008.

Authors:  Mugdha Gokhale; Bradley C Martin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-09-13       Impact factor: 2.890

2.  Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool.

Authors:  Alexander A Leung; Carol Keohane; Stuart Lipsitz; Eyal Zimlichman; Mary Amato; Steven R Simon; Michael Coffey; Nathan Kaufman; Bismarck Cadet; Gordon Schiff; Diane L Seger; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2013-04-18       Impact factor: 4.497

3.  Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs.

Authors:  Kristin Krigsman; Arne Melander; Anders Carlsten; Anders Ekedahl; J Lars Nilsson
Journal:  Pharm World Sci       Date:  2007-02

Review 4.  Drug-induced liver injury in older adults.

Authors:  Sarah J Mitchell; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-12

5.  Evaluation of the community pharmacist's behavior towards a prescription of antidiabetic and antiasthma drugs.

Authors:  Muaed J Alomar; Shareef Qandil; Hanan M A Al-Hilwani; Dima M Malkat; Claire Caroline
Journal:  Pharm Pract (Granada)       Date:  2011-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.